Nuke “They’d given up on the US market. They blew the EU rollout. But it’s obvious you omitted that. “
The US market is DEAD. Berg said “we anticipate Tx to continue to decline due to gV”. They aren’t doing anything to increase sales in the US. Without patent protection )R-IT patents are 100% unenforceable and worthless) there is no way to beat generics. The EU is the only future.
Blew the EU rollout???? Berg doesn’t expect France until 2024. Germany still won’t pay for new drugs. Italy and Spain are ongoing. That is how new drugs launch. Payers don’t want to pay for preventative drugs that don’t change biomarkers or have a measurable difference. V has been in the US for 11 years and still most insurance companies won’t pay.
News 
Market Data 
Discover 
